Wall Street Analysts Predict a 32.69% Upside in Chemed ( CHE ) : Here's What You Should Know
The mean of analysts' price targets for Chemed (CHE) points to a 32.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Chemed Corporation Declares Quarterly Dividend of 60 Cents - Chemed ( NYSE:CHE )
CINCINNATI, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Chemed Corporation ( NYSE:CHE ) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.
Chemed Corporation Declares Quarterly Dividend of 60 Cents
CINCINNATI, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Chemed Corporation ( NYSE:CHE ) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.
Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference
CINCINNATI, Ohio, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Chemed Corporation ( NYSE: CHE ) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. ( ET ) at the PGA National Resort in Palm Beach ...
Schwartz Offloads 28,000 Chemed ( CHE ) Shares Valued at $13 Million
Schwartz Investment Counsel disclosed that it reduced its position in Chemed Corporation ( NYSE:CHE ) by 28,771 shares during the quarter, according to a 13F form filed with the Securities and Exchange Commission on October 29, 2025 ( SEC filing ) .
EULAV Asset Management Unloads $13 Million of Chemed ( NYSE: CHE ) Stock: Should Investors Sell Too?
On October 28, 2025, EULAV Asset Management reported selling 28,313 shares of Chemed ( NYSE:CHE ) in Q3 2025, an estimated $12.82 million trade based on the average price during Q3 2025.According to a filing with the Securities and Exchange Commission dated October 28, 2025, EULAV Asset ...
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Axogen ( NASDAQ:AXGN ) , Bloom Energy ( NYSE:BE )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday. Shares of Caterpillar Inc ( NYSE:CAT ) rose sharply during Wednesday's session after the company reported better-than-expected third-quarter financial results.
CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash
Chemed's Q3 miss sends shares lower as shrinking margins and weaker EPS overshadow steady revenue gains from VITAS and Roto-Rooter.
Chemed ( CHE ) Lags Q3 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of -2.23% and -0.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Chemed Reports Third-Quarter 2025 Results
CINCINNATI, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- Chemed Corporation ( Chemed ) ( NYSE: CHE ) , which operates VITAS Healthcare Corporation ( VITAS ) , the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning ...
OPCH or CHE: Which Is the Better Value Stock Right Now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
ServiceTitan Announces Strategic Partnership With Roto-Rooter
LOS ANGELES, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- ServiceTitan ( Nasdaq: TTAN ) , the software platform that powers the trades, today announced a strategic partnership with Roto-Rooter, the largest provider of plumbing, drain cleaning, and water cleanup services in North America.
Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday - Ameresco ( NYSE:AMRC ) , Affiliated Managers Group ( NYSE:AMG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim raised Inventiva S.A. IVA price target from $9 to $13. Guggenheim analyst Etzer Darout ...
This Zscaler Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Chemed ( NYSE:CHE ) , Performance Food Gr ( NYSE:PFGC )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Meta Marshall upgraded SailPoint, Inc.
Why Is Chemed ( CHE ) Up 9.3% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's How Much $100 Invested In Chemed 15 Years Ago Would Be Worth Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 15 years by 2.47% on an annualized basis producing an average annual return of 14.73%. Currently, Chemed has a market capitalization of $6.15 billion.
VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer - Chemed ( NYSE:CHE )
MIRAMAR, Fla., July 30, 2025 ( GLOBE NEWSWIRE ) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation CHE, today announced that Nicholas M.
Why Chemed Stock Is Plummeting Today
Chemed missed expectations on both the top and bottom lines with its second-quarter earnings.
Chemed ( CHE ) Q2 Earnings Miss Estimates
Chemed (CHE) delivered earnings and revenue surprises of -10.67% and +0.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ASTH vs. CHE: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. ( ASTH Quick QuoteASTH - ) and Chemed ( CHE Quick QuoteCHE - ) . But which of these two stocks offers value investors a better bang for their buck right now?
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Applied Optoelectronics ( NASDAQ:AAOI ) , Arcutis Biotherapeutics ( NASDAQ:ARQT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Ryan Koontz initiated coverage on Applied Optoelectronics, Inc.
Analysts Estimate Chemed ( CHE ) to Report a Decline in Earnings: What to Look Out for
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking Into Chemed's Recent Short Interest - Chemed ( NYSE:CHE )
Chemed's CHE short percent of float has fallen 14.96% since its last report. The company recently reported that it has 431 thousand shares sold short, which is 3.41% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.83 days to cover their ...
Price Over Earnings Overview: Chemed
In the current market session, Chemed Inc. CHE price is at $454.81, after a 0.24% spike. However, over the past month, the stock fell by 16.85%, and in the past year, by 16.24%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to ...
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 10 years by 1.47% on an annualized basis producing an average annual return of 12.85%. Currently, Chemed has a market capitalization of $6.64 billion.
ASTH or CHE: Which Is the Better Value Stock Right Now?
ASTH vs. CHE: Which Stock Is the Better Value Option?
Here's How Much You Would Have Made Owning Chemed Stock In The Last 10 Years - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 13.26%. Currently, Chemed has a market capitalization of $6.90 billion.
Crude Oil Moves Lower; Joby Aviation Shares Surge - BitMine Immersion Techs ( AMEX:BMNR ) , Artelo Biosciences ( NASDAQ:ARTL )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.3% on Monday. The Dow traded up 0.45% to 44,014.63 while the NASDAQ gained 0.32% to 20,338.93. The S&P 500 also rose, gaining, 0.33% to 6,193.57. Financials shares jumped by 0.8% on Monday.
Reasons to Add Align Technology Stock to Your Portfolio Now
ALGN's Invisalign growth, iTero innovation and solid finances fuel optimism despite forex headwinds.
Is the Market Bullish or Bearish on Chemed? - Chemed ( NYSE:CHE )
Chemed's CHE short percent of float has risen 23.16% since its last report. The company recently reported that it has 422 thousand shares sold short, which is 3.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.61 days to cover their ...
Here's How Much $1000 Invested In Chemed 10 Years Ago Would Be Worth Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 10 years by 4.45% on an annualized basis producing an average annual return of 15.36%. Currently, Chemed has a market capitalization of $8.04 billion.
Here's How Much $100 Invested In Chemed 15 Years Ago Would Be Worth Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 15 years by 4.84% on an annualized basis producing an average annual return of 16.72%. Currently, Chemed has a market capitalization of $8.33 billion.
AMED or CHE: Which Is the Better Value Stock Right Now?
AMED vs. CHE: Which Stock Is the Better Value Option?
Is the Market Bullish or Bearish on Chemed? - Chemed ( NYSE:CHE )
Chemed's CHE short percent of float has fallen 3.17% since its last report. The company recently reported that it has 231 thousand shares sold short, which is 1.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.62 days to cover their ...
P/E Ratio Insights for Chemed - Chemed ( NYSE:CHE )
In the current market session, Chemed Inc. CHE price is at $571.49, after a 2.57% spike. However, over the past month, the stock fell by 4.54%, and in the past year, by 2.35%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par ...
Here's How Much You Would Have Made Owning Chemed Stock In The Last 10 Years - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 10 years by 5.49% on an annualized basis producing an average annual return of 16.17%. Currently, Chemed has a market capitalization of $8.36 billion.
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care ( OPCH Quick QuoteOPCH - ) and Chemed ( CHE Quick QuoteCHE - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look ...
Here's How Much You Would Have Made Owning Chemed Stock In The Last 20 Years - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 20 years by 6.22% on an annualized basis producing an average annual return of 14.22%. Currently, Chemed has a market capitalization of $8.40 billion.
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
Chemed ( CHE ) Surpasses Q1 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of 0.54% and 1.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Here's How Much $1000 Invested In Chemed 15 Years Ago Would Be Worth Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 15 years by 6.62% on an annualized basis producing an average annual return of 17.1%. Currently, Chemed has a market capitalization of $8.62 billion.
OPCH or CHE: Which Is the Better Value Stock Right Now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
Why Is Chemed ( CHE ) Up 4.5% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's How Much $1000 Invested In Chemed 20 Years Ago Would Be Worth Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 20 years by 6.62% on an annualized basis producing an average annual return of 14.89%. Currently, Chemed has a market capitalization of $8.91 billion.
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care ( OPCH Quick QuoteOPCH - ) and Chemed ( CHE Quick QuoteCHE - ) . But which of these two stocks presents investors with the better value opportunity right now?
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 10 years by 6.85% on an annualized basis producing an average annual return of 17.75%. Currently, Chemed has a market capitalization of $8.60 billion.
OPCH or CHE: Which Is the Better Value Stock Right Now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Chemed ( CHE ) Surpasses Q4 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of 0.59% and 1.78%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
$1000 Invested In Chemed 20 Years Ago Would Be Worth This Much Today - Chemed ( NYSE:CHE )
Chemed CHE has outperformed the market over the past 20 years by 6.01% on an annualized basis producing an average annual return of 14.21%. Currently, Chemed has a market capitalization of $8.25 billion.
